Carolinas Wealth Consulting’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-33
Closed -$456 1072
2023
Q4
$456 Sell
33
-29
-47% -$403 ﹤0.01% 933
2023
Q3
$879 Buy
+62
New +$872 ﹤0.01% 845
2023
Q2
Sell
-64
Closed -$628 1077
2023
Q1
$628 Buy
64
+8
+14% +$85 ﹤0.01% 963
2022
Q4
$596 Buy
+56
New +$651 ﹤0.01% 983

Other funds holding DVAX

Carolinas Wealth Consulting's DVAX Position: Q1 2024 in Review

Carolinas Wealth Consulting sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 33 shares — an estimated $456 sold.

Carolinas Wealth Consulting first reported a position in DVAX in Q4 2022 and held it in 4 quarters. The position peaked at $879 in Q3 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Carolinas Wealth Consulting reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 33 Dynavax Technologies shares in Q1 2024, an estimated $456.
  • Carolinas Wealth Consulting first reported a position in Dynavax Technologies in Q4 2022 and held it in 4 quarters.
  • Carolinas Wealth Consulting's Dynavax Technologies position peaked at $879 in Q3 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.